Jiang R - Search Results

1

CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study.

Liu Z, Wang J, Meng Z, Wang X, Zhang C, Qin T, Chen J, Jiang X, Wang L, Lin L, Zhang X, Chen P, Huang C, Jiang R, Li K. Liu Z, et al. Among authors: jiang r, jiang x. Cancer Med. 2018 Jul;7(7):3011-3021. doi: 10.1002/cam4.1584. Epub 2018 Jun 1. Cancer Med. 2018. PMID: 29856135 Free PMC article.

2

Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.

Xu WJ, Huang C, Wang J, Jiang RC, Wang LC, Lin L, Liu ZJ, Sun BC, Li K. Xu WJ, et al. Chin Med J (Engl). 2011 Sep;124(18):2883-9. Chin Med J (Engl). 2011. PMID: 22040497

3

Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.

Jiang R, Jin Z, Liu Z, Sun L, Wang L, Li K. Jiang R, et al. Mol Diagn Ther. 2011 Dec 1;15(6):347-52. doi: 10.1007/BF03256470. Mol Diagn Ther. 2011. PMID: 22208386

4

Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.

Wang X, Jiang R, Li K. Wang X, et al. Among authors: jiang r. Cell Biochem Biophys. 2014 Jul;69(3):633-40. doi: 10.1007/s12013-014-9845-3. Cell Biochem Biophys. 2014. PMID: 24554485

5

Association of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma.

Jiang R, Wang X, Jin Z, Li K. Jiang R, et al. J Cancer. 2016 Jan 10;7(3):324-34. doi: 10.7150/jca.13422. eCollection 2016. J Cancer. 2016. PMID: 26918046 Free PMC article.

6

Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.

Jiang R, Wang X, Li K. Jiang R, et al. Oncotarget. 2016 May 3;7(18):26823-36. doi: 10.18632/oncotarget.8662. Oncotarget. 2016. PMID: 27072585 Free PMC article.

7

[Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].

Kong Q, Wang XY, Jiang RC, Ba Y, Li K. Kong Q, et al. Among authors: jiang rc. Zhonghua Zhong Liu Za Zhi. 2016 Apr;38(4):294-9. doi: 10.3760/cma.j.issn.0253-3766.2016.04.010. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27087377 Chinese.

8

Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.

Zhi Q, Wang Y, Wang X, Yue D, Li K, Jiang R. Zhi Q, et al. Among authors: jiang r. Oncotarget. 2016 Oct 4;7(40):64798-64809. doi: 10.18632/oncotarget.11703. Oncotarget. 2016. PMID: 27623437 Free PMC article.

9

Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer.

Wang YQ, Zhi QJ, Wang XY, Yue DS, Li K, Jiang RC. Wang YQ, et al. Oncol Lett. 2017 Oct;14(4):4331-4338. doi: 10.3892/ol.2017.6660. Epub 2017 Jul 24. Oncol Lett. 2017. PMID: 28943947 Free PMC article.

10

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level.

Cao L, Wang X, Li S, Zhi Q, Wang Y, Wang L, Li K, Jiang R. Cao L, et al. Among authors: jiang r. J Cancer. 2017 Sep 15;8(16):3251-3260. doi: 10.7150/jca.21118. eCollection 2017. J Cancer. 2017. PMID: 29158797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,828 results

Search Page

Filters